• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粒细胞集落刺激因子可有效动员 TCR γδ 和 NK 细胞,为异基因造血干细胞移植提供潜在增强移植物抗白血病效应的同种异体移植物。

Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation.

机构信息

Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

出版信息

Front Immunol. 2021 Mar 10;12:625165. doi: 10.3389/fimmu.2021.625165. eCollection 2021.

DOI:10.3389/fimmu.2021.625165
PMID:33777007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7988077/
Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is a potential cure for patients with hematological malignancies but substantial risks of recurrence of the malignant disease remain. TCR γδ and NK cells are perceived as potent innate effector cells in HSCT and have been associated with post-transplant protection from relapse in clinical studies. Immunocompetent cells from the donor are crucial for patient outcomes and peripheral blood stem cells (PBSC) are being increasingly applied as graft source. G-CSF is the preferential mobilizing agent in healthy donors for PBSC grafts, yet effects of G-CSF on TCR γδ and NK cells are scarcely uncovered and could influence the graft composition and potency of these cells. Therefore, we analyzed T and NK cell subsets and activation markers in peripheral blood samples of 49 donors before and after G-CSF mobilization and-for a subset of donors-also in the corresponding graft samples using multicolor flowcytometry with staining for CD3, CD4, CD8, TCRαβ, TCRγδ, Vδ1, Vδ2, HLA-DR, CD45RA, CD197, CD45RO, HLA-DR, CD16, CD56, and CD314. We found that TCR γδ cells were mobilized and harvested with an efficiency corresponding that of TCR αβ cells. For TCR γδ as well as for TCR αβ cells, G-CSF preferentially mobilized naïve and terminally differentiated effector (TEMRA) cells over memory cells. In the TCR γδ cell compartment, G-CSF preferentially mobilized cells of the nonVδ2 types and increased the fraction of HLA-DR positive TCR γδ cells. For NK cells, mobilization by G-CSF was increased compared to that of T cells, yet NK cells appeared to be less efficiently harvested than T cells. In the NK cell compartment, G-CSF-stimulation preserved the proportion of CD56dim NK effector cells which have been associated with relapse protection. The expression of the activating receptor NKG2D implied in anti-leukemic responses, was significantly increased in both CD56dim and CD56bright NK cells after G-CSF stimulation. These results indicate differentiated mobilization and altering properties of G-CSF which could improve the effects of donor TCR γδ and NK cells in the processes of graft-versus-leukemia for relapse prevention after HSCT.

摘要

异基因造血干细胞移植(HSCT)是治疗血液系统恶性肿瘤患者的一种潜在方法,但恶性疾病复发的风险仍然很大。TCRγδ 和 NK 细胞被认为是 HSCT 中的强大先天效应细胞,并与临床研究中移植后复发的保护有关。供者的免疫活性细胞对患者的预后至关重要,外周血干细胞(PBSC)作为移植物来源越来越多地被应用。G-CSF 是健康供者用于 PBSC 移植物的首选动员剂,但 G-CSF 对 TCRγδ 和 NK 细胞的影响尚未被充分揭示,可能会影响这些细胞的移植物组成和效力。因此,我们使用多色流式细胞术分析了 49 名供者在 G-CSF 动员前后以及一部分供者在相应移植物样本中的外周血样本中的 T 和 NK 细胞亚群和激活标志物,这些标志物使用 CD3、CD4、CD8、TCRαβ、TCRγδ、Vδ1、Vδ2、HLA-DR、CD45RA、CD197、CD45RO、HLA-DR、CD16、CD56 和 CD314 进行染色。我们发现 TCRγδ 细胞的动员和收获效率与 TCRαβ 细胞相当。对于 TCRγδ 和 TCRαβ 细胞,G-CSF 优先动员幼稚和终末分化效应(TEMRA)细胞,而不是记忆细胞。在 TCRγδ 细胞区室中,G-CSF 优先动员非 Vδ2 类型的细胞,并增加 HLA-DR 阳性 TCRγδ 细胞的比例。与 T 细胞相比,G-CSF 对 NK 细胞的动员增加,但 NK 细胞的收获效率似乎低于 T 细胞。在 NK 细胞区室中,G-CSF 刺激保留了与复发保护相关的 CD56dim NK 效应细胞的比例。在 G-CSF 刺激后,与白血病反应有关的激活受体 NKG2D 的表达在 CD56dim 和 CD56bright NK 细胞中均显著增加。这些结果表明 G-CSF 的分化动员和改变特性可能会改善供者 TCRγδ 和 NK 细胞在 HSCT 后移植物抗白血病过程中的作用,从而预防复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937a/7988077/43e0e72e027c/fimmu-12-625165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937a/7988077/e2b75eb46a3b/fimmu-12-625165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937a/7988077/d92baff1078e/fimmu-12-625165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937a/7988077/ab94943c192d/fimmu-12-625165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937a/7988077/43e0e72e027c/fimmu-12-625165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937a/7988077/e2b75eb46a3b/fimmu-12-625165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937a/7988077/d92baff1078e/fimmu-12-625165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937a/7988077/ab94943c192d/fimmu-12-625165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937a/7988077/43e0e72e027c/fimmu-12-625165-g004.jpg

相似文献

1
Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation.粒细胞集落刺激因子可有效动员 TCR γδ 和 NK 细胞,为异基因造血干细胞移植提供潜在增强移植物抗白血病效应的同种异体移植物。
Front Immunol. 2021 Mar 10;12:625165. doi: 10.3389/fimmu.2021.625165. eCollection 2021.
2
Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.异基因干细胞移植后 2 个月 TCRγδ 细胞免疫重建高的患者总生存、无复发生存和移植物抗宿主病发生率降低。
Front Immunol. 2019 Aug 22;10:1997. doi: 10.3389/fimmu.2019.01997. eCollection 2019.
3
Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.粒细胞集落刺激因子动员健康供者外周血造血干细胞导致淋巴细胞亚群优先动员。
Front Immunol. 2018 May 2;9:845. doi: 10.3389/fimmu.2018.00845. eCollection 2018.
4
Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease.粒细胞集落刺激因子影响 T 细胞的 TRGV 和 TRDV 受体库的分布和克隆性以及移植物抗宿主病。
J Transl Med. 2011 Dec 15;9:215. doi: 10.1186/1479-5876-9-215.
5
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease.粒细胞集落刺激因子动员的同种异体移植物含有与急性和慢性移植物抗宿主病风险相关的活化免疫细胞亚群。
Biol Blood Marrow Transplant. 2016 Apr;22(4):658-668. doi: 10.1016/j.bbmt.2015.12.015. Epub 2015 Dec 29.
6
Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation.异基因造血干细胞移植后供体中及早期免疫重建时高自然杀伤细胞剂量可改善无病生存率。
Front Immunol. 2020 May 29;11:1068. doi: 10.3389/fimmu.2020.01068. eCollection 2020.
7
Homeostatic γδ T Cell Contents Are Preserved by Granulocyte Colony-Stimulating Factor Priming and Correlate with the Early Recovery of γδ T Cell Subsets after Haploidentical Hematopoietic Stem Cell Transplantation.稳态 γδ T 细胞含量通过粒细胞集落刺激因子启动得以维持,并与单倍体造血干细胞移植后 γδ T 细胞亚群的早期恢复相关。
Biol Blood Marrow Transplant. 2018 Feb;24(2):252-259. doi: 10.1016/j.bbmt.2017.10.027. Epub 2017 Oct 20.
8
Regulatory γδ T cells induced by G-CSF participate in acute graft-versus-host disease regulation in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation.G-CSF 动员的异基因外周血造血干细胞移植中,由 G-CSF 诱导的调节性 γδ T 细胞参与急性移植物抗宿主病的调节。
J Transl Med. 2018 May 25;16(1):144. doi: 10.1186/s12967-018-1519-2.
9
Lower incidence of grade II-IV acute Graft-versus-Host-Disease in pediatric patients recovering with high Vδ2+ T cells after allogeneic stem cell transplantation with unmanipulated bone marrow grafts: a prospective single-center cohort study.异基因造血干细胞移植后未处理骨髓移植物中 Vδ2+ T 细胞高恢复的儿童患者急性移植物抗宿主病 II-IV 级发生率较低:一项前瞻性单中心队列研究。
Front Immunol. 2024 Jul 29;15:1433785. doi: 10.3389/fimmu.2024.1433785. eCollection 2024.
10
Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation.移植后巨细胞病毒感染的潜在有益效应。
Front Immunol. 2018 Mar 1;9:389. doi: 10.3389/fimmu.2018.00389. eCollection 2018.

引用本文的文献

1
The unique immune evasion mechanisms of the mpox virus and their implication for developing new vaccines and immunotherapies.猴痘病毒独特的免疫逃逸机制及其对开发新型疫苗和免疫疗法的意义。
Virol Sin. 2024 Oct;39(5):709-718. doi: 10.1016/j.virs.2024.08.008. Epub 2024 Aug 22.
2
Controversial role of γδ T cells in colorectal cancer.γδ T细胞在结直肠癌中的争议性作用。
Am J Cancer Res. 2024 Apr 15;14(4):1482-1500. doi: 10.62347/HWMB1163. eCollection 2024.
3
[Impact of SARS-CoV-2 infection on graft composition and early transplant outcomes following allogeneic hematopoietic stem cell transplantation].

本文引用的文献

1
Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation.异基因造血干细胞移植后供体中及早期免疫重建时高自然杀伤细胞剂量可改善无病生存率。
Front Immunol. 2020 May 29;11:1068. doi: 10.3389/fimmu.2020.01068. eCollection 2020.
2
Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD.剖析异基因 HSCT 的生物学特性,在最大限度降低 GvHD 的同时增强 GvT 效应。
Nat Rev Clin Oncol. 2020 Aug;17(8):475-492. doi: 10.1038/s41571-020-0356-4. Epub 2020 Apr 20.
3
Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer.
[严重急性呼吸综合征冠状病毒2感染对异基因造血干细胞移植后移植物组成及早期移植结局的影响]
Zhonghua Xue Ye Xue Za Zhi. 2023 Nov 14;44(11):890-899. doi: 10.3760/cma.j.issn.0253-2727.2023.11.002.
4
γδ T cells: origin and fate, subsets, diseases and immunotherapy.γδ T 细胞:起源与命运、亚群、疾病与免疫治疗。
Signal Transduct Target Ther. 2023 Nov 22;8(1):434. doi: 10.1038/s41392-023-01653-8.
5
Gamma delta T-cell reconstitution after allogeneic HCT: A platform for cell therapy.异基因造血干细胞移植后 γδ T 细胞重建:细胞治疗的平台。
Front Immunol. 2022 Aug 29;13:971709. doi: 10.3389/fimmu.2022.971709. eCollection 2022.
6
Mining the multifunction of mucosal-associated invariant T cells in hematological malignancies and transplantation immunity: A promising hexagon soldier in immunomodulatory.挖掘黏膜相关恒定 T 细胞在血液系统恶性肿瘤和移植免疫中的多功能性:免疫调节中具有广阔前景的六边形战士
Front Immunol. 2022 Aug 16;13:931764. doi: 10.3389/fimmu.2022.931764. eCollection 2022.
嵌合抗原受体细胞疗法:克服抗癌障碍
Cancers (Basel). 2020 Mar 31;12(4):842. doi: 10.3390/cancers12040842.
4
Impact of γδ T cells on clinical outcome of hematopoietic stem cell transplantation: systematic review and meta-analysis.γδ T 细胞对造血干细胞移植临床结局的影响:系统评价和荟萃分析。
Blood Adv. 2019 Nov 12;3(21):3436-3448. doi: 10.1182/bloodadvances.2019000682.
5
Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells.髓系恶性肿瘤中的自然杀伤细胞:免疫监视、NK 细胞功能障碍以及增强内源性 NK 细胞的药理学机会
Front Immunol. 2019 Oct 11;10:2357. doi: 10.3389/fimmu.2019.02357. eCollection 2019.
6
Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.异基因干细胞移植后 2 个月 TCRγδ 细胞免疫重建高的患者总生存、无复发生存和移植物抗宿主病发生率降低。
Front Immunol. 2019 Aug 22;10:1997. doi: 10.3389/fimmu.2019.01997. eCollection 2019.
7
Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.移植物工程与过继免疫治疗:促进造血干细胞移植后免疫耐受的新方法。
Front Immunol. 2019 Jul 10;10:1342. doi: 10.3389/fimmu.2019.01342. eCollection 2019.
8
Adaptive NK cell reconstitution is associated with better clinical outcomes.适应性自然杀伤细胞重建与更好的临床结果相关。
JCI Insight. 2019 Jan 24;4(2):e125553. doi: 10.1172/jci.insight.125553.
9
Regulatory γδ T cells induced by G-CSF participate in acute graft-versus-host disease regulation in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation.G-CSF 动员的异基因外周血造血干细胞移植中,由 G-CSF 诱导的调节性 γδ T 细胞参与急性移植物抗宿主病的调节。
J Transl Med. 2018 May 25;16(1):144. doi: 10.1186/s12967-018-1519-2.
10
Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.粒细胞集落刺激因子动员健康供者外周血造血干细胞导致淋巴细胞亚群优先动员。
Front Immunol. 2018 May 2;9:845. doi: 10.3389/fimmu.2018.00845. eCollection 2018.